Research & development > Clinical diagnostics

Now you know what makes you itch

27 May, 2013

Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as the sensation of itch.


Don’t breathe your way to worse cholesterol

20 May, 2013

Academic researchers have found that breathing motor vehicle emissions triggers a change in high-density lipoprotein (HDL) cholesterol, altering its cardiovascular protective qualities so that it actually contributes to clogged arteries.


Developing a faster diagnosis of bacterial meningitis

22 April, 2013

Using joint funding from the Paige Weatherspoon Foundation and the Macquarie University Office of Commercialisation, a team of researchers have recently made headway in developing a faster diagnosis for bacterial meningitis.


Rapid test device has global impact

15 April, 2013

Two engineers have changed the way blood is collected and tested thanks to a world-first, fully integrated rapid test device, designed and developed in Australia.


Screening human blood for disease markers

25 March, 2013

Researchers at The Scripps Research Institute in Florida have developed cutting-edge technology that can successfully screen human blood for disease markers. This tool may hold the key to better diagnosing and understanding today’s most pressing and puzzling health conditions, including autoimmune diseases.


Saliva test could detect early stages of HPV-linked oral cancer

14 March, 2013

The University of Queensland has received a major funding boost to its development of a saliva test to diagnose the early stages of head and neck cancer linked to human papillomavirus (HPV).


Type 1 diabetes testing could become faster, cheaper

11 March, 2013

Work by Perth researchers could revolutionise testing for type 1 diabetes around the world.


New blood test set to detect ‘forgotten’ women’s cancer

27 February, 2013

Garvan researchers, in collaboration with The Gynaecologic Cancer Centre at Royal Hospital for Women, are developing the first-ever early detection test for ovarian cancer based on epigenetic changes that are associated with ovarian cancer risk.


UC researching new forms of tumour detection

11 February, 2013

Researchers at the University of Canterbury are working on new forms of tumour detection in the hope of reducing the annual cancer toll.


Researchers identify enzyme involved in deadly brain tumours

25 January, 2013

In a study published in Neuro-Oncology, researchers at Mayo Clinic identify an important association between the naturally occurring enzyme Kallikrein 6, also known as KLK6, and the malignant tumour glioblastoma multiforme.


Scientists pinpoint molecular signals that make some women prone to miscarriage

21 January, 2013

Scientists have identified molecular signals that control whether embryos are accepted by the womb and appear to function abnormally in women who have suffered repeated miscarriages.


Potential new treatment for gastrointestinal cancers discovered

17 January, 2013

Researchers have identified a complex of proteins that promotes the growth of some types of colon and gastric cancers, and shown that medications that block the function of this complex have the potential to be developed into a new treatment for these diseases.


Saliva glands may diagnose Parkinson’s disease

15 January, 2013 by Lauren Davis

New research from Mayo Clinic in Arizona and Banner Sun Health Research Institute suggests that testing a portion of a person’s saliva gland may be a way to diagnose the degenerative disorder Parkinson’s disease. The study will be presented at the American Academy of Neurology’s annual meeting in San Diego in March.


Alzheimer’s to be diagnosed online

10 January, 2013

The early onset of Alzheimer’s disease could be detected using a simple online test, according to scientists from the Queensland Brain Institute (QBI) at The University of Queensland (UQ).


Researchers find new molecule to target in pancreatic cancer treatment

08 January, 2013

Researchers at Mayo Clinic in Florida have identified a new target to improve treatment of pancreatic ductal adenocarcinoma cancer, which accounts for more than 95% of pancreatic cancer cases.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd